Skip to main content
    L

    LifeMD Inc Preferred Series A (LFMDP)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $19.66
    -0.31 (-1.53%)

    Last updated: Nov 16, 2026 at 4:15 PM ET

    LifeMD Inc Preferred Series A (LFMDP) Financials: Revenue, Profit and Cash Flow

    Updated Sep 30, 2026. Financial statements from company filings, amounts in US dollars.

    LifeMD Inc Preferred Series A reported revenue of $194.06M for the fiscal year ended Dec 31, 2025, down 8.7% from the year before. That year, net income was -$7.11M with a net margin of -3.7%, operating cash flow was $8.28M and free cash flow was -$1.24M. The quarter ended Sep 30, 2026 had revenue of $44.63M and net income of -$4.47M.

    Revenue and Margins

    The operating margin was -4.0% in the fiscal year ended Dec 2025, the highest of the 9 years shown with an operating margin. Over the 9 years to Dec 2025, revenue grew from $5.24M, a compound annual rate of 49.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$194.06M-8.7%79.8%-4.0%-3.7%
    Dec 2024$212.45M+39.3%88.7%-7.6%-8.9%
    Dec 2023$152.55M+28.2%87.6%-9.5%-13.5%
    Dec 2022$119.03M+28.2%84.3%-36.5%-38.3%
    Dec 2021$92.88M+149.0%80.6%-58.5%-65.6%
    Dec 2020$37.29M+199.1%76.1%-155.0%-162.3%
    Dec 2019$12.47M+49.8%79.7%-23.2%-25.2%
    Dec 2018$8.32M+64.7%76.3%-24.7%-14.9%
    Dec 2017$5.05M-3.5%70.6%-21.1%-23.9%
    Dec 2016$5.24MN/A62.9%-22.4%-21.1%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$194.06M$212.45M$152.55M$119.03M$92.88M$37.29M$12.47M$8.32M$5.05M$5.24M
    Cost of revenue$39.29M$24.07M$18.90M$18.67M$18.00M$8.91M$2.53M$1.97M$1.48M$1.95M
    Gross profit$154.76M$188.39M$133.65M$100.37M$74.88M$28.39M$9.94M$6.36M$3.57M$3.29M
    Research and development$7.35M$9.51M$6.06M$2.97M$948.16K$446.75K$222.88K$120.54K$0$0
    Operating income-$7.67M-$16.14M-$14.49M-$43.45M-$54.30M-$57.82M-$2.89M-$2.06M-$1.07M-$1.17M
    Net income-$7.11M-$18.88M-$20.60M-$45.54M-$60.90M-$60.52M-$3.14M-$1.24M-$1.21M-$1.11M
    EBITDA-$1.52M-$6.65M-$8.21M-$35.92MN/A-$57.42M-$2.55M-$1.86MN/A-$1.06M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$44.63M$47.28M$50.16M$46.87M$60.17M$62.22M$65.70M$64.25M$53.27M$50.66M$44.14M$44.86M
    Gross profit$36.38M$42.00M$42.56M$38.35M$52.76M$54.79M$57.05M$54.82M$48.26M$45.64M$39.54M$39.50M
    Operating income-$4.47M-$7.13M-$8.93M-$1.10M-$1.97M-$906.77K$2.54M$1.02M-$4.00M-$6.31M-$6.17M-$2.17M
    Net income-$4.47M-$7.08M-$8.87M-$1.50M-$3.81M-$2.07M$1.38M-$106.27K-$4.66M-$6.88M-$6.77M-$3.73M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $642.42K by $36.14M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$70.41M$72.46M$58.48M$25.67M$49.92M$13.40M$3.45M$2.62M$1.26M$789.82K
    Current assets$51.83M$48.73M$42.60M$11.31M$44.92M$12.41M$2.75M$1.61M$1.26M$789.82K
    Cash and equivalents$36.79M$35.00M$33.15M$3.96M$41.33M$9.18M$1.11M$180.09K$141.38K$182.56K
    Total liabilities$47.25M$76.51M$52.91M$32.97M$24.10M$14.22M$4.58M$1.80M$640.97K$1.15M
    Short-term debt$642.42K$8.95M$930.78K$3.55M$670.89K$872.13K$814.73K$247.42K$167.48K$206.37K
    Long-term debtN/A$9.89M$17.93MN/AN/AN/AN/AN/AN/AN/A
    Shareholder equity$23.16M-$5.49M$3.51M-$6.83M$26.85M$1.35M-$988.18K$897.70K$881.92K-$355.17K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$66.29M$59.89M$70.12M$70.41M$65.98M$73.56M$73.61M$72.46M$72.56M$63.82M$61.46M$58.48M
    Total liabilities$66.86M$51.93M$55.09M$47.25M$62.62M$73.18M$74.01M$76.51M$78.51M$65.88M$60.16M$52.91M
    Cash and equivalents$21.92M$25.14M$34.48M$36.79M$23.79M$36.23M$34.39M$35.00M$37.59M$35.70M$35.11M$33.15M
    Shareholder equity-$579.65K$7.97M$15.04M$23.16M$1.31M-$1.78M-$2.33M-$5.49M-$7.72M-$4.21M-$845.30K$3.51M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$8.28M$17.51M$8.82M-$22.94M-$33.09M-$12.13M$251.41K-$905.52K-$817.22K-$407.91K
    Capital expenditures$9.52M$11.54M$8.73M$12.89M$3.40M$398.14K$247.37K$100.00K$0$0
    Free cash flow-$1.24M$5.98M$86.95K-$35.83M-$36.49M-$12.53M$4.04K-$1.01M-$817.22K-$407.91K
    Dividends paid$3.11M$3.11M$3.11M$3.11M$871.48K$1.29M$871.48K$871.48K$878.86K$330.00K
    Investing cash flow$6.91M-$11.54M-$8.73M-$13.91M-$3.40M-$798.14K-$100.00K$141.44K$63.38K$219.89K
    Financing cash flow-$13.41M-$4.12M$29.10M-$528.20K$68.64M$21.00M$775.12K$802.79K$776.03K$357.49K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$949.63K-$6.93M$444.62K-$3.28M-$147.14K$8.64M$3.07M$1.57M$6.20M$4.54M$5.20M$5.71M
    Capital expenditures$1.49M$3.59M$105.18K$155.46K$6.57M$2.87M$2.87M$2.72M$3.49M$3.13M$2.19M$2.22M
    Free cash flow-$2.44M-$10.51M$339.45K-$3.44M-$6.71M$5.77M$201.05K-$1.15M$2.71M$1.41M$3.01M$3.50M
    Last 12 quarters

    Frequently Asked Questions About LFMDP

    What is LifeMD Inc Preferred Series A's annual revenue?

    LifeMD Inc Preferred Series A reported revenue of $194.06M for the fiscal year ended Dec 31, 2025.

    How fast is LifeMD Inc Preferred Series A's revenue growing?

    Revenue was down 8.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 17.7%.

    Is LifeMD Inc Preferred Series A profitable?

    No. LifeMD Inc Preferred Series A reported net income of -$7.11M for the fiscal year ended Dec 31, 2025, with a net margin of -3.7%.

    How much free cash flow does LFMDP generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $8.28M minus capital expenditures of $9.52M produced free cash flow of -$1.24M.

    How much debt does LifeMD Inc Preferred Series A have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $642.42K and cash and equivalents of $36.79M.